Table 6.
Patient 2
|
Patient 9
|
Patient 10
|
||||
---|---|---|---|---|---|---|
FR titer | IFN-γ response | FR titer | IFN-γ response | FR titer | IFN-γ response | |
Pretreatment | 3 | 1,100 | 50 | 3,340 | 1,000 | 1,825 |
Posttreatment | 6 | 0 | 1,650 | 390 | 900 | 1,550 |
NOTE: Serum FR titers were determined using ELISA. FR levels varied between patients, with patient 2 having low amounts and patient 10 high amounts both before and after treatment. Patient 9 experienced an increase in FR levels over the course of treatment. There was no consistent correlation between FR levels and inhibition of IFN-γ response against IGROV-1 tumor cells.